Inclusion criteria | |
• Male or female of any race • Aged ≥18 years on the day of the research interview • Confirmed diagnosis of recurrent and/or metastatic HNSCC (oral cavity, oropharynx, hypopharynx, or larynx) • Patient has received treatment for recurrent and/or metastatic HNSCC in the past 12 months • Patient has a WHO Performance Status of 0 or 1a • Patient is willing to take part in a 90-min face-to-face interview (or via Skype or telephone if face-to-face is not possible) • In the opinion of the patient’s physician, patient has the cognitive, reading and linguistic capacities sufficient to allow her/him to actively participate in a 90-min interview • Patient speaks US-English as a first language and can read and write US-English • Patient has personally read, signed and dated a legally effective written informed consent form prior to admission to the study | |
Exclusion criteria | |
• Patient has a significant psychiatric or physical co-morbid condition that would, in the opinion of the patient’s physician, prevent his/her participation in this study • Patient is currently abusing drugs or alcohol or has done so in 12 months prior to interview • Patient is unwilling or unable to comply with the requirements of the study |